Tirzepatide
Dual GIP / GLP-1 receptor agonist. Widely studied in metabolic and incretin research.
Background
Tirzepatide is a 39-amino-acid synthetic peptide combining structural elements of native GIP with engineered GLP-1 agonism. C20 fatty-diacid moiety extends plasma half-life.
Research-grade material; each batch is independently verified for identity, purity and safety, with TFA and heavy-metal screening run on every batch.
Certificate of analysis & pricing
Current-batch COA and reseller pricing unlock with catalogue access.
COA hosted on the lab's own site
Related compounds